Dry Eye Syndrome

5

Review clinical trials related to Dry Eye Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)

Systemic lupus erythematosus (SLE) is a chronic, systemic autoimmune disease characterized by B cell hyperactivity and Sjorgren's disease (SjD) is a chronic, multisystem autoimmune disease characterized by lacrimal and salivary gland inflammation, with resultant dryness of the eyes and mouth and occasional glandular enlargement. ABBV-319 exhibits potential B cell depletion in SLE and SjD which are characterized by B cell hyperactivity. The purpose of this study is to assess the pharmacokinetics, safety, and efficacy of ABBV-319 in adult participants with SLE or SjD. ABBV-319 is an investigational drug being developed for the treatment of SLE and SjD. Participants are placed in 1 of 6 groups called treatment arms. Each group receives a different dose of ABBV-319 depending on whether they have SLE or SjD. Around 36 adult participants with SLE or SjD will be enrolled at approximately 10 sites worldwide. Participants will receive 2 doses of IV ABBV-319 21 days apart and will be followed for up to 343 days. There may be higher treatment burden for participants in this trial compared to their standard of care (due to study procedures). Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires.

Participants needed: 36
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: AbbVieUpdated: May 19, 2026Locations: 7
Eligibility criteria

Systemic Lupus Erythematosus (SLE) Population - Clinical diagnosis of SLE at lea... [+4]

History of infection as defined in the protocol. [+4]

Status: Recruiting

Proteomic and Metabolomic Lacrimal Fingerprint in Diverse Pathologies of the Ocular Surface

This study aims to obtain the lacrimal fingerprint for frequent pathologies of the ocular surface and establish a normative base for each of them.

Participants needed: 300
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Centre hospitalier de l'Université de Montréal (CHUM)Updated: Apr 27, 2026Locations: 2
Eligibility criteria

Patients younger than 18 years old; [+1]

Status: Recruiting

Autologous Serum Eye Drops in Dry Eye Syndrome

This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.

Participants needed: 70
Trial details
Age: Up to 18Biological sex: AllType: InterventionalSponsor: The General Authority for Teaching Hospitals and InstitutesUpdated: Dec 22, 2025Locations: 1
Eligibility criteria

Children aged less than 18 years. [+2]

Active ocular infection. [+3]

Status: Not yet recruiting

Exosome-miRNA and Transcriptome Profiling of Dry Eye Syndrome and Sjogren's Syndrome

This study combines data from two trials testing acupuncture (ACUDES) and a Chinese herbal tea bag TBDESJS for Dry Eye Syndrome and Sjögren's syndrome. Both treatments improved tear production. Researchers will now analyze participants' blood remaining samples and other data to understand how these therapies work. They will use advanced methods to identify tiny RNA molecules and immune system activity. This integrated approach aims to explain how acupuncture and TBDESJS improve dryness and support their use in managing these conditions.

Participants needed: 220
Trial details
Age: 20-75Biological sex: AllType: ObservationalSponsor: Taipei Veterans General Hospital, TaiwanUpdated: Jun 26, 2024Locations: 1
Eligibility criteria

aged between 20 and 75 years Schirmer's test less than 10 mm/5 min

Inclusion Criteria: primary or secondary SS aged between 20 and 75 years fulfill... [+3]

Status: Not yet recruiting

Dry Eye Syndrome, Healthy Control, Sjögren's Syndrome and Other Inflammation Disease in Taiwan Biobank

The comprehensive analysis of health records, TCM constitution, biomarker, and whole-genome sequencing among dry eye syndrome, healthy control, Sjögren's syndrome and other inflammation disease in Taiwan: an integrated analysis between Taiwan Biobank and Sjögren's syndrome Database

Participants needed: 100,000
Trial details
Age: 20-75Biological sex: AllType: ObservationalSponsor: Taipei Veterans General Hospital, TaiwanUpdated: Aug 11, 2022Locations: 1
Eligibility criteria

aged between 20 and 75 years [+1]

aged between 20 and 75 years [+3]